Scientists from the Spanish National Research Council have developed a wearable visual simulator, which allows patients to experience how their vision will improve after having cataract surgery.

The lightweight binocular visual simulator is autonomous and is worn like a helmet. It is the first device of its kind and has been designed to allow patients and surgeons to see the effects of an intraocular multifocal lens, which allows seeing at different distances, in a realistic way before the lens is implanted. The findings from the research were published in the journal Scientific Reports.

A new electronic decision support tool for managing asthma has the potential to improve the quality of asthma care in primary care settings, as the result of a new study led by St. Michael's Hospital in Canada.

The research, published in the European Respiratory Journal, aimed to determine whether the Electronic Asthma Management System (eAMS) could help close existing gaps in asthma care. The system is a first-of-its-kind evidence-based computerised decision support tool.

Abbott has inked a non-exclusive deal to integrate insulin dose data from Novo Nordisk‘s pre-filled and connected pens with its FreeStyle Libre mobile app and cloud-based system.

The companies touted that integrating the products will allow healthcare professionals, caregivers and users to easily view glucose and insulin data, as well as make more informed treatment decisions.

Medtronic has received Breakthrough Device designation from the FDA for its Personalised Closed Loop insulin pump system, currently in development.

The technology is designed to automate insulin delivery in a way that is real-time, personalised and adapts to the user. The system will also provide insights and predictive diagnostics unique to the individual, with a goal of dramatically simplifying diabetes management for the patient.